Cytokinetics
CYTKCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Cytokinetics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/8/2025 | Sell | Callos, Andrew | EVP, Chief Commercial Officer | $66.0 | $68,730 |
| 12/5/2025 | Sell | Callos, Andrew | EVP, Chief Commercial Officer | $66.0 | $3,461,452 |
| 12/2/2025 | Sell | Malik, Fady Ibraham | EVP Research & Development | $63.9 | $140,558 |
| 12/2/2025 | Sell | Henderson, John T. | Director | $63.9 | $559,125 |
| 12/1/2025 | Sell | Harrington, Robert Arthur | Director | $66.8 | $143,620 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)